Abstract
Despite being the most common endocrinological disorder of reproductive aged women, polycystic ovary syndrome (PCOS) remains a complex disease of unknown etiology. Patients spend an average of two years of clinical evaluation with at least three health professionals before diagnosis. As PCOS remains a diagnosis of exclusion, there is room for improvement in diagnostic classification. Although the use of Antimullerian hormone (AMH) as a diagnostic test has shown promise, it has limitations. Our laboratory has identifiedvariation in levels of activating autoantibody (AAb) to the second extracellular loop of the gonadotropin-releasing hormone receptor (GnRHR) associated with PCOS in infertile patients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
